compounding pharmacies

News

FDA ramps up its pushback against compounded GLP-1s

In a move that will please Novo Nordisk and Eli Lilly, the FDA sent warnings to 30 telehealth firms, accusing them of illegally marketing GLP-1 drugs.

News

Black and white image of a white flag of surrender

Novo Nordisk rises as Hims & Hers backs down on oral GLP-1

Novo Nordisk's battered stock enjoyed a reprieve after Hims & Hers abandoned plans to launch a compounded version of the new Wegovy pill.

News

Hims & Hers copies Novo Nordisk's new Wegovy pill

Competition has already arrived for Novo Nordisk's Wegovy pill, as telehealth company Hims & Hers launches a compounded version.

R&D

pharmaphorum podcast Episode 223, Shawn Hodges, Revelation Pharma

On US drug shortages and compounding pharmacies, with Shawn ...

Shawn Hodges, CEO of Revelation Pharma, discusses the true state of drug shortages in the US at the moment and the role of compounding pharmacies.

R&D

The importance of understanding the differences between 503A...

Inside the ecosystem of compounding pharmacies, 503A and 503B facilities are distinct.

News

FDA lends a hand to Novo, Lilly on illegal GLP-1 imports

The FDA has set up a green list of overseas sources for GLP-1 ingredients to try to block imports of illegitimate and potentially unsafe materials.

FDA ramps up its pushback against compounded GLP-1s

Novo Nordisk rises as Hims & Hers backs down on oral GLP-1

Hims & Hers copies Novo Nordisk's new Wegovy pill

On US drug shortages and compounding pharmacies, with Shawn ...

The importance of understanding the differences between 503A...

FDA lends a hand to Novo, Lilly on illegal GLP-1 imports

NHS to offer Wegovy to a million more people in England

Using AI-driven synthetic personas to take your insights fur...

compounding pharmacies

Editor's Picks